Traditional trial start-up workflows often follow a sequential path, from feasibility to contracting, then regulatory ...

There is a wealth of data, reviews, articles, and regulatory guidance on how to conduct clinical trials to take a biosimilar from conception to market. However, there is minimal literature describing ...

The evolution of artificial intelligence in research and development marks a new era as generative AI, agentic systems, and other breakthroughs swiftly progress from concept to transformative practice ...